This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 24 Dec 2015  |  Europe  |  Market Research

    Analysis of the Western European Clinical Laboratories Market

    Public Hospital Service Outsourcing to Drive the Growth of Independent Reference Labs

    Laboratory consolidations and outsourcing of services are providing more opportunities to the clinical labs. How the market is going to shape up and how the laboratory services structure is transforming in Western Europe is analyzed in this research service. The study provides market overview, market engineering measurements and revenue forecasts, ...

    $6,000.00
  2. 22 Dec 2015  |  Europe  |  Market Research

    Healthcare Services Market Outlook for Eastern Europe

    Country-level Analysis of Healthcare Systems and Private Hospital Markets

    This research service provides an overview of the healthcare systems of selected countries and a competitive analysis of their private hospital markets. The study includes data and analyses on each countrys economic, demographic, and epidemic conditions, the healthcare system and reforms, healthcare expenditure and fund flow system, healthcare infr...

    $4,950.00
  3. 08 Dec 2015  |  Global  |  Market Research

    Analysis of the Global Fibrinogen Market and Product Pipeline

    Launch of Topical and Ready-to-Use Fibrin Sealants Impetus to Growth

    The increased demand for fibrinogen and the development of innovative delivery systems such as sprays and patches are fuelling the growth of the fibrinogen market. This research service provides a detailed assessment of the global fibrinogen market, covering the current market scenario and growth prospects for the period 2015–2020. Both marketed ...

    $6,000.00
  4. 30 Sep 2015  |  Europe  |  Market Research

    Profiling the Top Mergers and Acquisition Within Medical Devices Space

    Changing Healthcare Dynamics Driving the M&A

    The landscape of healthcare is rapidly changing worldwide as governments are reducing healthcare spending through means such as reimbursement cuts. The medical devices market bears the direct brunt of these measures. To overcome this, medical device companies are involved in active mergers and acquisitions (M&A). The study analyses the key factors ...

    $1,500.00
  5. 30 Sep 2015  |  Global  |  Market Research

    A Product and Pipeline Analysis of the Global Immunoglobulin Market

    Trends in Communicable and Non-Communicable Diseases Drug Pipeline

    Immunoglobulin therapies are life-saving medicines that have been in use for more than 60 years. They provide the patient with a variety of antibodies and are often used as a last line of defense in many severe inflammatory diseases. In some conditions, they are life-saving. However, immunoglobulin therapies are expensive. Despite this, global dem...

    $4,950.00
  6. 29 Sep 2015  |  Europe  |  Market Research

    Analysis of the European Digital and Computed Radiography Markets

    Workflow Integration Provides Potential for Growth

    This research service presents an analysis of the digital and computed radiography markets in Europe. It also provides an in-depth analysis of the market and discusses market characteristics such as size, revenue forecasts, drivers, restraints, market penetration and market attractiveness for both the digital radiography (DR) and the computed rad...

    $4,950.00
  7. 29 Sep 2015  |  Global  |  Market Research

    Insights for CFOs betting on Intellectual Property

    Type 2 diabetes is one of the most significant global health concerns of modern times. The size of the diabetes therapeutics market has stimulated a vast and growing pipeline of potential new therapies aimed at the unmet needs of tighter glucose control, improved safety profiles, and greater convenience to patients. This research service evaluates ...

    $4,950.00
  8. 29 Sep 2015  |  Global  |  Market Research

    Global Review of Intellectual Property (IP) Funds

    Big pharma companies increasingly consider outsourcing manufacturing to CMOs as a strategic move because of the uncomplicated, timely, and cost-effective services CMOs provide as well as the fact that companes can then focus on their core competencies. This study provides market overview, market engineering measurements, revenue forecasts, competit...

    $4,950.00
  9. 28 Sep 2015  |  Global  |  Market Research

    Vital Signs The Analyst's Perspective - August 2015 Issue

    This issue of Vital Signs discusses the FDA's clearnace of the first 3-D printed prescription drug, Illumina's formation of consumer genomics company Helix, Response Genetics' acquisition of Cancer Genetics, and Roche's acquisition of GeneWEAVE.

    $450.00
  10. 02 Sep 2015  |  Global  |  Market Research

    The New Age of Regenerative Medicine

    Why Stem Cell Therapy?

    Cell therapy is the fastest growing segment of the Regenerative Medicine (RM) industry. It comprises both immune cell therapy and stem cell therapy; however, stem cell therapy makes up the largest part of this segment. The global cell therapy market is driven by the success of stem cell treatments in treating or curing life-threatening diseases suc...

    $1,500.00